Before + Afters – Chemotherapy
The before + afters in our Chemotherapy section are real case study results sent to us by our customers, physicians and professional partners. Individual results may vary. We hope you share the benefits of our Oncology safe products with your family, friends or colleagues that are about to undergo cancer treatment.
“I had a severe skin reaction from two powerful chemotherapy drugs (Adriamycin / Cytoxin) that were administered every other day for four weeks. The worst reaction was on my legs which had raised red areas and many of these were blisters. We had tried Calendula Oil by Bodyceuticals. The rash would subside and then come back worse than before. Tracy introduced me to NeoGenesis Recovery serum. I applied it twice a day to the affected areas. In one week, I had a huge improvement. The redness faded, the raised areas diminished, the blisters went away, and the itching stopped. Recovery serum is a miracle product. I highly recommend it to anyone with skin issues from chemo.” – CP
“My father is treated with Xeloda for recurrent colon cancer. He suffered from cracks and bruises on his hands, fingers, and feet after chemotherapy. When I ordered ‘NeoGenesis Recovery’ for the first time, I didn’t expect too much. Recovery is amazing. I am now ordering from you regularly. I don’t know how many people have the same problem after chemotherapy with Xeloda (which is the regular treatment for colon and breast cancer), but Recovery can be a huge help.” – EA
“I would like to say thank you so much for sending the products. I am completely in love. As you know I take chemotherapy, called Rituximab. The infusion causes a serious rash. I have applied Nystatin powder prescribed by my doctor, but that requires at least a week for some relief and several weeks to totally heal. After just one treatment visit and the products they gave me (Recovery + Intensive Moisturizer) I am in less discomfort.” – HB
Do you want to see more Oncology before + afters? Follow NeoGenesis on Facebook, Instagram, TikTok, Twitter, and YouTube.